Posted by Generex on LinkedIn 23 minutes ago Wh
Post# of 36537
(Total Views: 382)
Posted On: 10/28/2020 12:25:47 PM
Posted by Generex on LinkedIn 23 minutes ago
While people exposed to #SARSCoV2 have been shown to acquire #immunity to the coronavirus for a few months, our Ii-key #vaccine aims to immunize against SARS-CoV-2 over a longer period by inducing long-term T-cell memory responses.
#sarscov2 #covid19 #immunology #immunotherapy #immunooncology #tcells #biotechnology #coronavirus #Iikeypeptide
While people exposed to #SARSCoV2 have been shown to acquire #immunity to the coronavirus for a few months, our Ii-key #vaccine aims to immunize against SARS-CoV-2 over a longer period by inducing long-term T-cell memory responses.
#sarscov2 #covid19 #immunology #immunotherapy #immunooncology #tcells #biotechnology #coronavirus #Iikeypeptide
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼